Concentrix CorpCNXC
Price$27.01

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $10B+4.0% YoYTTM through 31 May 2026
Net Income -$1.3B-623.2% YoYTTM through 31 May 2026
Free Cash Flow $513.5MTTM through 31 May 2026

Margins

Current
Gross Margin34.0%
EBITDA Margin-3.6%
Operating Margin4.7%
Net Margin-13.2%

Returns

-48.7%ROE
-12.5%ROA

Balance Sheet Health

Debt / Equity1.70x
Current Ratio1.17x
Net Debt$4.5B
Cash & Equivalents$255.6M

Quality Metrics

Altman Z-Score0.81
Piotroski F-Score4 / 9
FCF Margin5.1%
Earnings-Beat Rate25.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $9.8B
Diluted EPS-$20.84TTM
'19'20'21'22'23'24'25
FY2025: $-20.30

Dividend

$0.72Per share, FY20262.36%Yield+7.6%5-yr growth

Capital Allocation

Capex Intensity2.3%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.